SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?


To: marc ultra who wrote (1368)12/5/1997 1:28:00 AM
From: james  Respond to of 4676
 
marc, <<>>. You are absolutely right. But if methx works so great, why FDA don't ask for preclinical data for IND filing for psoriasis? Methx is a none-specific immuno-suppressor used for a lot of purposes. No doubt a great drug, but for psoriasis/RA better drugs are badly needed. Also I am not saying AS (I-CAM) will be a better drug, but never hurt to charge ahead if ISIP is coming so far & getting closer.

regards